Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kidney function may change how Weight-Loss drug works

NCT ID NCT07076030

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times

Summary

This study looked at how the weight-management drug petrelintide behaves in people with different levels of kidney function. Researchers compared 39 adults with normal kidneys to those with mild, moderate, or severe kidney impairment. The goal was to see if kidney problems change how the drug moves through the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Charité Research Organisation GmbH

    Berlin, 10117, Germany

Conditions

Explore the condition pages connected to this study.